BG-P-TAT (NanoPharmaceuticals)

N/A

Report date: 2024/09/02 11:48:24
NME

Base Information

Drug NameBG-P-TAT (NanoPharmaceuticals)
Drug Alias NameNP855NP-855
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeuroblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNanoPharmaceuticals LLC
China Registration ClassN/A

Develop Information

Active CompaniesNanoPharmaceuticals LLC
Inactive CompaniesN/A
Active IndicationsNeuroblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A